Reports for RANBAXY PHARMACEUTICALS CANADA INC.

Company Name

RANBAXY PHARMACEUTICALS CANADA INC.

Totals

Shortage reports

72

Actual shortage: 0 (0%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 72 (100%)

Discontinuation Reports

32

To be discontinued: 0 (0%)
Discontinued: 32 (100%)
Reversed: 0 (0%)

Late reports

47 (45%)

Overdue reports

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RAN-LISINOPRIL 20MG TABLET Resolved 2020-12-03 2021-05-01 129527
RAN-ROPINIROLE 5.0MG TABLET Resolved 2020-12-03 2021-07-13 129547
RAN-ROPINIROLE 0.25MG TABLET Resolved 2021-01-31 2021-05-01 132979
RAN-LISINOPRIL 20MG TABLET Resolved 2021-08-04 2021-12-07 143621
RAN-ROPINIROLE 2.0MG TABLET Resolved 2021-10-21 2021-11-26 147748
RAN-EZETIMIBE 10MG TABLET Resolved 2022-01-06 2022-02-15 152160
RAN-ROPINIROLE 1.0MG TABLET Resolved 2022-01-06 2022-02-15 152163
RAN-ROPINIROLE 0.25MG TABLET Resolved 2022-04-12 2024-05-09 158553
RAN-ROPINIROLE 1.0MG TABLET Resolved 2022-08-19 2022-11-25 167426
RAN-ROPINIROLE 2.0MG TABLET Resolved 2022-08-19 2024-05-09 167429
RAN-ROPINIROLE 5.0MG TABLET Resolved 2022-08-19 2024-05-09 167432
RAN-ROPINIROLE 1.0MG TABLET Resolved 2022-12-13 2024-05-09 178240

Showing 61 to 72 of 72

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 41 to 32 of 32